NPC1L1 and metabolic syndrome: NPC1L1 functions as a cholesterol importer to mediate intestinal cholesterol absorption [4,5], and is reported to be a target molecule of ezetimibe, a cholesterol absorption inhibitor used clinically for dyslipidemia [6].